EU Court Ruling Makes Orphan Drug Application Route More Attractive
This article was originally published in The Pink Sheet Daily
Executive Summary
A ruling by the EU’s Court of Justice overturning a previous decision by the European Commission on Laboratoire CTRS’s liver drug should make orphan drug applications more attractive in the region.